French Guiana Wellness Network: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on French Guiana Wellness Network.

Press releases published on March 5, 2026

Mar. 5, 2026

New Book “Avoiding Toxins” Offers a Physician’s Practical Playbook for Navigating America’s Hidden Environmental Exposure Crisis

Indeterminate GlobeNewswire

Mar. 5, 2026

Kyverna Therapeutics to Present New Data from Neuroimmunology Franchise at AAN 2026

Indeterminate GlobeNewswire

Mar. 5, 2026

CooperCompanies Announces First Quarter 2026 Results

Indeterminate GlobeNewswire

Mar. 5, 2026

Tonix Pharmaceuticals Announces Publication of Clinical Pharmacokinetic Studies of TONMYA™ and Prototype Formulations in the Journal Clinical Pharmacology in Drug Development

Indeterminate GlobeNewswire

Mar. 5, 2026

Outlook Therapeutics Provides Update Following Type A Meeting with FDA Regarding ONS-5010/LYTENAVA™ (bevacizumab-vikg)

Indeterminate GlobeNewswire

Mar. 5, 2026

Omada Health Announces GLP-1 Flex Care, Giving Employers a New, Flexible Path to Support Obesity Care

Indeterminate GlobeNewswire

Mar. 5, 2026

Nyxoah Publiera ses Résultats Financiers du Quatrième Trimestre et de l’Année 2025 le 19 Mars 2026

Indeterminate GlobeNewswire

Mar. 5, 2026

Nyxoah to Release Fourth Quarter and Full Year 2025 Financial Results on March 19, 2026

Indeterminate GlobeNewswire

Mar. 5, 2026

CAMP4 Reports Full Year 2025 Financial Results and Corporate Highlights

Indeterminate GlobeNewswire

Mar. 5, 2026

Regeneron Announces Investor Conference Presentation

Indeterminate GlobeNewswire

Mar. 5, 2026

Amneal to Participate in Upcoming Investor Conference

Indeterminate GlobeNewswire

Mar. 5, 2026

Atea Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Mar. 5, 2026

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Mar. 5, 2026

Metagenomi Therapeutics Reports Business Updates and Full Year 2025 Financial Results

Indeterminate GlobeNewswire

Mar. 5, 2026

NextCure Provides Business Update and Reports Full Year 2025 Financial Results

Indeterminate GlobeNewswire

Mar. 5, 2026

AEON Biopharma Abstract Accepted for Presentation at 2026 American Academy of Neurology (AAN) Annual Meeting

Indeterminate GlobeNewswire

Mar. 5, 2026

Profound Medical Reports Fourth Quarter and Full Year 2025 Financial Results

Indeterminate GlobeNewswire

Mar. 5, 2026

BBOT Reports Fourth Quarter and Full Year 2025 Financial Results and Update on Corporate Progress

Indeterminate GlobeNewswire

Mar. 5, 2026

BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting

Indeterminate GlobeNewswire

Mar. 5, 2026

Omada Health Reports Fourth Quarter and Full-Year 2025 Results

Indeterminate GlobeNewswire